Defenses of affirmative action rely on faulty assumptions about the educational value of student-body diversity and the best ways to address educational inequities.
Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient?